Fundz

Ancilia Biosciences reported raising $10.1 Million in an initial SEC Form D filing, from an offering of $10.1 Million

PRIVATEApr 06, 2026

Amount Raised

$10.1 Million

$10.1 Million sold, per SEC Form D (first sale Feb 13, 2026)

Round Type

Venture

New YorkBiotechnology

Who to call at Ancilia Biosciences, and when

A new round usually means Ancilia Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ancilia Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ancilia Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ancilia Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ancilia Biosciences

Location

3960 BROADWAY, 6TH FLOOR

New York, New York, United States

About

Ancilia develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. Our approach harnesses the natural function of CRISPR to enhance bacterial immunity against viruses and effectively modulate the human microbiome.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ancilia Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDavid A., Chief Technology OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ancilia Biosciences's next move

See what Strategic adds

Ancilia Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.